506 related articles for article (PubMed ID: 2174276)
1. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
Gordeladze JO
Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C stimulates adenylate cyclase activity in prolactin-secreting rat adenoma (GH4C1) pituicytes by inactivating the inhibitory GTP-binding protein Gi.
Gordeladze JO; Björo T; Torjesen PA; Ostberg BC; Haug E; Gautvik KM
Eur J Biochem; 1989 Aug; 183(2):397-406. PubMed ID: 2569396
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial regulation of pituitary adenylate cyclase-activating polypeptide (PACAP)-induced production of cyclic AMP in ATT-20 corticotrophs: major involvement of Rolipram-sensitive and insensitive phosphodiesterases.
Koch B; Lutz-Bucher B
Mol Cell Endocrinol; 1995 Jul; 112(1):27-34. PubMed ID: 7589782
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
Souness JE; Hassall GA; Parrott DP
Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
[TBL] [Abstract][Full Text] [Related]
5. Hormone-sensitive adenylate cyclase of prolactin-producing rat pituitary adenoma (GH4C1) cells: molecular organization.
Gordeladze JO; Sletholt K; Thorn NA; Gautvik KM
Eur J Biochem; 1988 Nov; 177(3):665-72. PubMed ID: 2904368
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
7. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
[TBL] [Abstract][Full Text] [Related]
9. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
Sette C; Iona S; Conti M
J Biol Chem; 1994 Mar; 269(12):9245-52. PubMed ID: 8132662
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
11. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
Kochetkova M; Burns FM; Souness JE
Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
[TBL] [Abstract][Full Text] [Related]
12. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
14. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
16. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
Kim DH; Lerner A
Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
[TBL] [Abstract][Full Text] [Related]
19. Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
Ezeamuzie CI
Eur J Pharmacol; 2001 Apr; 417(1-2):11-8. PubMed ID: 11301054
[TBL] [Abstract][Full Text] [Related]
20. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]